Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Research

A cheap and open HIV viral load technique applicable in routine analysis in a resource limited setting with a wide HIV genetic diversity

Authors: Elodie Téclaire Ngo-Malabo, Paul Alain Ngoupo T., Martin Zekeng, Valérie Ngono, Laure Ngono, Serge Alain Sadeuh-Mba, Richard Njouom, Anfumbom Kfutwah

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Background

HIV infection in Cameroon is characterized by a great viral diversity with all HIV-1 groups (M, N, O, and P) and HIV-2 in circulation. HIV group determination is very important if tailored viral load analysis and treatments are to be applied. In our laboratory, HIV viral load is carried out using two platforms; Biocentric and Abbott depending on the HIV group identified. Biocentric which quantifies HIV-1 group M is a cheap and open system useful in resource limited settings. The objective of this study was to compare the viral load analyses of serologically group-indeterminate HIV samples using the two platforms with the view of reducing cost.

Methods

Consecutive samples received between March and May 2014, and between August and September 2014 in our laboratory for HIV viral load analysis were included. All these samples were analyzed for their HIV groups using an in-house ELISA serotyping test. All HIV-1 group M samples were quantified using the Biocentric test while all other known atypical samples (HIV-1 groups N, O and P) were analyzed using the Abbott technique. HIV group-indeterminate samples (by serotyping) were quantified with both techniques.

Results

Among the 6355 plasma samples received, HIV-1 group M was identified in 6026 (94.82%) cases; HIV-1 group O, in 20 (0.31%); HIV-1 group M + O, in 3 (0.05%) and HIV-2, in 3 (0.05%) case. HIV-group indeterminate samples represented about 4.76% (303/6355) and only 231 of them were available for analysis by Abbott Real-Time HIV-1 and Generic HIV Viral Load techniques. Results showed that 188 (81.39%) samples had undetectable viral load in both techniques. All the detectable samples showed high viral load, with a mean of 4.5 log copies/ml (range 2.1–6.5) for Abbott Real-Time and 4.5 log copies/ml (range 2–6.4) for Generic HIV Viral Load. The mean viral load difference between the two techniques was 0.03 log10 copies/ml and a good correlation was obtained (r 2  = 0.89; P < 0.001).

Conclusion

Our results suggest that cheaper and open techniques such as Biocentric could be useful alternatives for HIV viral load follow-up quantification in resource limited settings like Cameroon; even with its high viral diversity.
Literature
1.
go back to reference Gao F, Chen Y, Levy DN, Conway JA, Kepler TB, Hui H. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol. 2004;78:2426–33.CrossRefPubMedPubMedCentral Gao F, Chen Y, Levy DN, Conway JA, Kepler TB, Hui H. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol. 2004;78:2426–33.CrossRefPubMedPubMedCentral
2.
3.
go back to reference Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemee V, Damond F, Robertson DL, Simon FA. New human immunodeficiency virus derived from gorillas. Nat Med. 2009;15:871–2.CrossRefPubMed Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemee V, Damond F, Robertson DL, Simon FA. New human immunodeficiency virus derived from gorillas. Nat Med. 2009;15:871–2.CrossRefPubMed
4.
go back to reference Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. HIV-1 nomenclature proposal. Science. 2000;288:55–6.CrossRefPubMed Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. HIV-1 nomenclature proposal. Science. 2000;288:55–6.CrossRefPubMed
5.
go back to reference Ayouba A, Akoua-Koffi C, Calvignac-Spencer S, Esteban A, Locatelli S, Li H, Li Y, Hahn BH, Delaporte E, Leendertz FH, Peeters M. Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural cote d'Ivoire. AIDS. 2013;27:2488–91.CrossRefPubMed Ayouba A, Akoua-Koffi C, Calvignac-Spencer S, Esteban A, Locatelli S, Li H, Li Y, Hahn BH, Delaporte E, Leendertz FH, Peeters M. Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural cote d'Ivoire. AIDS. 2013;27:2488–91.CrossRefPubMed
6.
go back to reference ORC-Macro INdlSa. Enquête Démographique et de Santé du Cameroun 2011. 2011. ORC-Macro INdlSa. Enquête Démographique et de Santé du Cameroun 2011. 2011.
7.
go back to reference Plantier JC, Djemai M, Lemee V, Reggiani A, Leoz M, Burc L, Vessiere A, Rousset D, Poveda JD, Henquell C, Gautheret-Dejean A, Barin F. Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol. 2009;47:2906–11.CrossRefPubMedPubMedCentral Plantier JC, Djemai M, Lemee V, Reggiani A, Leoz M, Burc L, Vessiere A, Rousset D, Poveda JD, Henquell C, Gautheret-Dejean A, Barin F. Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol. 2009;47:2906–11.CrossRefPubMedPubMedCentral
8.
go back to reference Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vezinet F. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol. 1997;71:8893–8.PubMedPubMedCentral Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vezinet F. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol. 1997;71:8893–8.PubMedPubMedCentral
9.
go back to reference Leoz M, Feyertag F, Kfutwah A, Mauclere P, Lachenal G, Damond F, De Oliveira F, Lemee V, Simon F, Robertson DL, Plantier JC. The two-phase emergence of non pandemic HIV-1 group O in Cameroon. PLoS Pathog. 2015;11:e1005029.CrossRefPubMedPubMedCentral Leoz M, Feyertag F, Kfutwah A, Mauclere P, Lachenal G, Damond F, De Oliveira F, Lemee V, Simon F, Robertson DL, Plantier JC. The two-phase emergence of non pandemic HIV-1 group O in Cameroon. PLoS Pathog. 2015;11:e1005029.CrossRefPubMedPubMedCentral
10.
go back to reference Rouet F, Liegeois F, Mouinga-Ondeme A, Kania D, Viljoen J, Wambua S. Ngo-Giang-Huong N, Menan H, Peeters M, Nerrienet E. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin Med Diagn. 2011;5:183–202.CrossRefPubMed Rouet F, Liegeois F, Mouinga-Ondeme A, Kania D, Viljoen J, Wambua S. Ngo-Giang-Huong N, Menan H, Peeters M, Nerrienet E. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin Med Diagn. 2011;5:183–202.CrossRefPubMed
11.
go back to reference Gueudin M, Leoz M, Lemee V, De Oliveira F, Vessiere A, Kfutwah A, Plantier JCA. New real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol. 2012;50:831–6.CrossRefPubMedPubMedCentral Gueudin M, Leoz M, Lemee V, De Oliveira F, Vessiere A, Kfutwah A, Plantier JCA. New real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol. 2012;50:831–6.CrossRefPubMedPubMedCentral
12.
go back to reference Kfutwah A, Lemee V, Ngono HV, De Oliveira F, Njouom R, Plantier JC. Field evaluation of the Abbott ARCHITECT HIV ag/ab combo immunoassay. J Clin Virol. 2013;58(Suppl 1):e70–5.CrossRefPubMed Kfutwah A, Lemee V, Ngono HV, De Oliveira F, Njouom R, Plantier JC. Field evaluation of the Abbott ARCHITECT HIV ag/ab combo immunoassay. J Clin Virol. 2013;58(Suppl 1):e70–5.CrossRefPubMed
13.
go back to reference Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Marechal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr. 2007;45:380–8.CrossRefPubMed Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Marechal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr. 2007;45:380–8.CrossRefPubMed
14.
go back to reference Schutten M, Peters D, Back NK, Beld M, Beuselinck K, Foulongne V, Geretti AM, Pandiani L, Tiemann C, Niesters HG. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol. 2007;45:1712–7.CrossRefPubMedPubMedCentral Schutten M, Peters D, Back NK, Beld M, Beuselinck K, Foulongne V, Geretti AM, Pandiani L, Tiemann C, Niesters HG. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol. 2007;45:1712–7.CrossRefPubMedPubMedCentral
15.
go back to reference Tejiokem MC, Faye A, Penda IC, Guemkam G, Ateba Ndongo F, Chewa G, Rekacewicz C, Rousset D, Kfutwah A, Boisier P, Warszawski J. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One. 2011;6:e21840.CrossRefPubMedPubMedCentral Tejiokem MC, Faye A, Penda IC, Guemkam G, Ateba Ndongo F, Chewa G, Rekacewicz C, Rousset D, Kfutwah A, Boisier P, Warszawski J. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One. 2011;6:e21840.CrossRefPubMedPubMedCentral
16.
go back to reference Heyndrickx l, Janssens w, Gürtler l, Zekeng l, Loussert-ajaka I, Vereecken K, Willems B, Coppens S, Ndumbe P, Fransen K, Saman E, Alary M, Groen1 gvd. Differential diagnosis of HIV type 1 group O and MInfection by polymerase chain reaction and Pstl restriction analysis of the pol gene fragment. AIDS Res Hum Retrovir. 14:973–7. Heyndrickx l, Janssens w, Gürtler l, Zekeng l, Loussert-ajaka I, Vereecken K, Willems B, Coppens S, Ndumbe P, Fransen K, Saman E, Alary M, Groen1 gvd. Differential diagnosis of HIV type 1 group O and MInfection by polymerase chain reaction and Pstl restriction analysis of the pol gene fragment. AIDS Res Hum Retrovir. 14:973–7.
17.
go back to reference Yang C, Dash BC, Simon F, van der Groen G, Pieniazek D, Gao F, Hahn BH, Lal RB. Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 2000;181:1791–1795. Yang C, Dash BC, Simon F, van der Groen G, Pieniazek D, Gao F, Hahn BH, Lal RB. Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 2000;181:1791–1795.
18.
19.
go back to reference Simon F, Souquiere S, Damond F, Kfutwah A, Makuwa M, Leroy E, Rouquet P, Berthier JL, Rigoulet J, Lecu A, Telfer PT, Pandrea I, Plantier JC, Barre-Sinoussi F, Roques P, Muller-Trutwin MC, Apetrei C. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retrovir. 2001;17:937–52.CrossRefPubMed Simon F, Souquiere S, Damond F, Kfutwah A, Makuwa M, Leroy E, Rouquet P, Berthier JL, Rigoulet J, Lecu A, Telfer PT, Pandrea I, Plantier JC, Barre-Sinoussi F, Roques P, Muller-Trutwin MC, Apetrei C. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retrovir. 2001;17:937–52.CrossRefPubMed
20.
go back to reference De Oliveira F, Mourez T, Vessiere A, Ngoupo PA, Alessandri-Gradt E, Simon F, Rousset D, Plantier JC. Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology. 2017;14:1.CrossRefPubMedPubMedCentral De Oliveira F, Mourez T, Vessiere A, Ngoupo PA, Alessandri-Gradt E, Simon F, Rousset D, Plantier JC. Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology. 2017;14:1.CrossRefPubMedPubMedCentral
21.
go back to reference Villabona-Arenas CJ, Domyeum J, Mouacha F, Butel C, Delaporte E, Peeters M, Mpoudi-Ngole E, Aghokeng AF. HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges. Infect Genet Evol. 2015; Villabona-Arenas CJ, Domyeum J, Mouacha F, Butel C, Delaporte E, Peeters M, Mpoudi-Ngole E, Aghokeng AF. HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges. Infect Genet Evol. 2015;
22.
go back to reference Vessiere A, Rousset D, Kfutwah A, Leoz M, Depatureaux A, Simon F, Plantier JC. Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun. J Acquir Immune Defic Syndr. 2010;53:107–10.CrossRefPubMed Vessiere A, Rousset D, Kfutwah A, Leoz M, Depatureaux A, Simon F, Plantier JC. Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun. J Acquir Immune Defic Syndr. 2010;53:107–10.CrossRefPubMed
23.
go back to reference Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS. 2003;17:2547–60.CrossRefPubMed Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS. 2003;17:2547–60.CrossRefPubMed
24.
go back to reference Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, Kjaer J, Knysz B, Phillips AN, Mocroft A. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Ther. 2006;11:707–15.PubMed Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, Kjaer J, Knysz B, Phillips AN, Mocroft A. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Ther. 2006;11:707–15.PubMed
25.
go back to reference Kfutwah AK, Tejiokem MC, Ateba FN, Ndongo JA, Penda IC, Ngoupo PA, Tchendjou P, Chewa G, Boisier P, Rouzioux C, Warszawski J, Faye A. Seronegativation in early treated HIV-infected infants: frequency and potential implications on care and follow-up in a resource-limited country. J Acquir Immune Defic Syndr. 2011;58:e43–6.CrossRefPubMed Kfutwah AK, Tejiokem MC, Ateba FN, Ndongo JA, Penda IC, Ngoupo PA, Tchendjou P, Chewa G, Boisier P, Rouzioux C, Warszawski J, Faye A. Seronegativation in early treated HIV-infected infants: frequency and potential implications on care and follow-up in a resource-limited country. J Acquir Immune Defic Syndr. 2011;58:e43–6.CrossRefPubMed
Metadata
Title
A cheap and open HIV viral load technique applicable in routine analysis in a resource limited setting with a wide HIV genetic diversity
Authors
Elodie Téclaire Ngo-Malabo
Paul Alain Ngoupo T.
Martin Zekeng
Valérie Ngono
Laure Ngono
Serge Alain Sadeuh-Mba
Richard Njouom
Anfumbom Kfutwah
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0893-3

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue